University Hospital Tuebingen
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- -
- Market Cap
- -
Kids Obesity Prevention Program - Study (KOP)
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2015-11-30
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 60
- Registration Number
- NCT02551978
Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 24
- Registration Number
- NCT02509728
- Locations
- 🇩🇪
University Hospital of Tuebingen, Tuebingen, Germany
Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolar Disorder
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-07-23
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 318
- Registration Number
- NCT02506322
- Locations
- 🇩🇪
Eberhard Karls University, Tuebingen, Germany
Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 21
- Registration Number
- NCT02468999
- Locations
- 🇩🇪
University of Tuebingen, Department of Internal Medicine IV, Tübingen, Germany
Buparlisib in Melanoma Patients Suffering From Brain Metastases (BUMPER)
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2017-05-03
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 22
- Registration Number
- NCT02452294
- Locations
- 🇩🇪
Department of Dermatology, University Hospital, Tuebingen, Germany
🇩🇪Department of Dermatology, University Hopsital, Dresden, Germany
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
- First Posted Date
- 2015-05-22
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 36
- Registration Number
- NCT02452307
Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-05-05
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 483
- Registration Number
- NCT02434107
- Locations
- 🇩🇪
Städtische Kliniken Darmstadt, Darmstadt, Germany
🇩🇪Ludwig-Maximilians-Universität, Munich, Germany
🇩🇪Universitätsklinkum Münster, Münster, Germany
Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2017-08-17
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 40
- Registration Number
- NCT02429440
Pre-meal Planning and Expected Satiety
- Conditions
- First Posted Date
- 2015-04-27
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 60
- Registration Number
- NCT02427152
- Locations
- 🇩🇪
University Clinic of Tuebingen, fMEG Center, Tuebingen, Germany
Apixaban for Treatment of Embolic Stroke of Undetermined Source
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-04-27
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 352
- Registration Number
- NCT02427126
- Locations
- 🇩🇪
Regiomed Kliniken Coburg GmbH Abt. II, Coburg, Germany
🇩🇪Neurologie, Klinikum Friedrichshafen GmbH, Friedrichshafen, Germany
🇩🇪Carl von Basedow KlinikumSaalekreis gGmbH, Merseburg, Germany
© Copyright 2024. All Rights Reserved by MedPath